Go Pro

This company recently went public with an IPO on Friday, July 24th 2026. They issued 8,580,000 shares at $13.00 - $15.00 per share. We will continue to update data for SCTX as it becomes available.

NASDAQ:SCTX

Scribe Therapeutics (SCTX) Stock Price, News & Analysis

$18.97 -2.68 (-12.38%)
As of 07/27/2026 04:00 PM Eastern

About Scribe Therapeutics Stock (NASDAQ:SCTX)

Advanced

Key Stats

Today's Range
$17.31
$22.75
50-Day Range
N/A
52-Week Range
$17.31
$25.49
Volume
419,014 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SCTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scribe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCTX Stock News Headlines

See More Headlines

SCTX Stock Analysis - Frequently Asked Questions

Scribe Therapeutics' stock was trading at $21.65 on July 24, 2026. Since then, SCTX shares have decreased by 12.4% and is now trading at $18.97.

Scribe Therapeutics (SCTX) raised $120 million in an initial public offering on Friday, July 24th 2026. The company issued 8,580,000 shares at $13.00-$15.00 per share.

Scribe Therapeutics's quiet period expires on Wednesday, September 2nd. Scribe Therapeutics had issued 8,580,000 shares in its initial public offering on July 24th. The total size of the offering was $128,700,000 based on an initial share price of $15.00. During Scribe Therapeutics' quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of SCTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:SCTX
CIK
1853921
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$36.28 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SCTX) was last updated on 7/28/2026 by MarketBeat.com Staff.
From Our Partners